30 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:46 PM
Natco Pharma Ltd.

BSE

  • 847.00 19.20 (2.32%)
  • Vol: 50929
  • BSE Code: 524816
  • PREV. CLOSE
    827.80
  • OPEN PRICE
    827.00
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    847.00(50)

NSE

  • 849.20 0.00 (0%)
  • Vol: 478379
  • NSE Code: NATCOPHARM
  • PREV. CLOSE
    849.20
  • OPEN PRICE
    828.00
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    849.20(2250)

Natco Pharma Ltd. Board Meetings

From date
To date
Source Date Board Meeting Date Details
06-Feb-201714-Feb-2017 Quarterly Results & Interim Dividend
04-Nov-201611-Nov-2016
01-Aug-201609-Aug-2016 Quarterly Results & Natco Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on August 09, 2016, inter alia, to consider the following items of businesses and related matters: 1. Unaudited financial Results for the quarter ended June 30, 2016. 2. To Consider Interim Dividend, if any, for the year 2016-17. 3. Convening of 33rd Annual General Meeting for the financial year 2015-16. 4. Consideration of Employee Stock Option Scheme (NATS0P2016) under SEBI (Share Based Employee Benefits) Regulations, 2014 & Interim Dividend
12-May-201626-May-2016 Audited Results
01-Feb-201611-Feb-2016 Quarterly Results & Interim Dividend
05-Nov-201513-Nov-2015 Quarterly Results & inter alia, to consider the following: o fix record date for Sub-Division of 1 (One) Equity Share of face value of Rs.10/- each into 5 (Five) Equity Shares of Rs. 2/- Each.
04-Aug-201512-Aug-2015 Quarterly Results & inter alia, to consider the following items of businesses and related matters: 1. Various options of raising of funds for one of the subsidiaries Timecap Overseas Ltd., Mauritius to be used for investment in Natcofarma Do Brasil Ltda, Brasil. 2. Convening of 32nd Annual General Meeting for the financial year 2014-15 3. To issue the notice of postal ballot and evoting to shareholders for approving the Scheme of Amalgamation of Natco Organics Limited into the Company and related matters. further, the "TRADING WINDOW" for dealing in the securities of the Company will be closed from August 04, 2015 to August 14, 2015 (both days inclusive).
19-May-201522-May-2015With reference to the SEBI Circular dated May 11, 2015, Natco Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 22, 2015 inter alia, will consider the following: 1. Formulation of Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive information pursuant to Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and 2. Code of Conduct to regulate, monitor and report trading by Insiders pursuant to Regulation 9 of the said Regulations.
12-May-201522-May-2015 A meeting of the Board of Directors of the Company will be held on May 22, 2015, to consider the following : 1. Approval of the unaudited financial Results for the quarter ending March, 2015 along with Audited Annual Accounts for the year 2014-2015. 2. Approval of increase of equity investment percentage in the Company to 49% to Foreign Institutional Investors (FIIs) / Foreign Portfolio Investors etc. 3. Further issue of shares or Convertible Securities of any nature in the form of Private Placement, Qualified Institutional Placement (QIP) to Foreign Institutional Investors (FIIs), Qualified Institutional Buyers or any other investors etc. 4. Merger of Natco Organics Limited(100% subsidiary Company) into Natco Pharma Limited 5. Consideration of Employee Stock Option Scheme under SEBI (Share Based Employee Benefits) Regulations, 2014. 6. Convening of Extraordinary General Meeting of the Members. Further, TRADING WINDOW for dealing in the securities of the Company will be closed from May 12, 2015 to May 24, 2015 (both days inclusive). Trading window will be opened from May 25, 2015. & Audited Results
30-Jan-201511-Feb-2015 Quarterly Results & Interim Dividend
31-Oct-201412-Nov-2014 Quarterly Results